Recent research suggests that Ozempic and other GLP-1 receptor agonists, commonly used for weight loss, may offer unexpected ...

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more ...

The announcement follows new research that suggested drugs like Wegovy, Mounjaro and Ozempic slashed the risk of contracting the disease. Scientists from Israel said the drugs, also known as GLP ...

First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...

A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

Scientists herald 150 new jabs and pills to tackle obesity going through the research pipeline - but issue urgent warning to ...

Bad reactions to popular weight-loss drugs, including Ozempic and Wegovy ... a week later she was rushed to hospital after experiencing 'massive blood clots'. She was then referred to a colorectal ...

The team reviewed electronic health records (EHRs) from more than 100 million patients in the US, including over 20,000 who were taking Ozempic. They looked at their risk of developing ...

The explosive popularity of GLP-1 (Glucagon-Like Peptide-1) drugs for addressing weight loss, diabetes and obesity, such as Ozempic and Munjaro are useful for a limited number of people and will ...

Rheumatoid arthritis patients face higher avoidable hospitalization risks, especially for heart failure and pulmonary edema, within 3-5 years post-diagnosis. Older age, glucocorticoid exposure ...